CN102812131A - 病毒细胞嗜性的识别 - Google Patents
病毒细胞嗜性的识别 Download PDFInfo
- Publication number
- CN102812131A CN102812131A CN2010800502050A CN201080050205A CN102812131A CN 102812131 A CN102812131 A CN 102812131A CN 2010800502050 A CN2010800502050 A CN 2010800502050A CN 201080050205 A CN201080050205 A CN 201080050205A CN 102812131 A CN102812131 A CN 102812131A
- Authority
- CN
- China
- Prior art keywords
- cell
- receptor
- virus
- hsa
- mir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003612 virological effect Effects 0.000 title description 11
- 230000005101 cell tropism Effects 0.000 title description 3
- 241000700605 Viruses Species 0.000 claims abstract description 122
- 239000002679 microRNA Substances 0.000 claims abstract description 107
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 71
- 108700011259 MicroRNAs Proteins 0.000 claims abstract description 61
- 238000000034 method Methods 0.000 claims abstract description 61
- 208000015181 infectious disease Diseases 0.000 claims abstract description 17
- 238000000338 in vitro Methods 0.000 claims abstract description 6
- 108091070501 miRNA Proteins 0.000 claims description 62
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 51
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims description 48
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims description 45
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 34
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 34
- 230000008569 process Effects 0.000 claims description 18
- 230000008859 change Effects 0.000 claims description 16
- 102000005962 receptors Human genes 0.000 claims description 15
- 108020003175 receptors Proteins 0.000 claims description 15
- 108091061613 Homo sapiens miR-638 stem-loop Proteins 0.000 claims description 12
- 101000746022 Homo sapiens CX3C chemokine receptor 1 Proteins 0.000 claims description 10
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 claims description 8
- 102100039196 CX3C chemokine receptor 1 Human genes 0.000 claims description 8
- 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 claims description 8
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 claims description 7
- 102100036305 C-C chemokine receptor type 8 Human genes 0.000 claims description 7
- 102100025618 C-X-C chemokine receptor type 6 Human genes 0.000 claims description 7
- 108010061304 CXCR6 Receptors Proteins 0.000 claims description 7
- 101100015688 Caenorhabditis elegans gpr-1 gene Proteins 0.000 claims description 7
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims description 6
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims description 6
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims description 6
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 claims description 6
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 6
- 101000678892 Homo sapiens Atypical chemokine receptor 2 Proteins 0.000 claims description 6
- 101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 claims description 6
- 108010018951 Interleukin-8B Receptors Proteins 0.000 claims description 6
- 241001430294 unidentified retrovirus Species 0.000 claims description 6
- 102100037853 C-C chemokine receptor type 4 Human genes 0.000 claims description 5
- 108091069046 Homo sapiens let-7g stem-loop Proteins 0.000 claims description 5
- 108091069090 Homo sapiens miR-149 stem-loop Proteins 0.000 claims description 5
- 108091063808 Homo sapiens miR-574 stem-loop Proteins 0.000 claims description 5
- 108091063720 Homo sapiens miR-575 stem-loop Proteins 0.000 claims description 5
- 238000003757 reverse transcription PCR Methods 0.000 claims description 5
- -1 hsa-miR-663 Proteins 0.000 claims description 4
- 230000001524 infective effect Effects 0.000 claims description 4
- 102100022718 Atypical chemokine receptor 2 Human genes 0.000 claims 2
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims 2
- 238000012360 testing method Methods 0.000 abstract description 10
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 136
- 241000894007 species Species 0.000 description 17
- 239000000370 acceptor Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000000523 sample Substances 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 241000910071 Pyrobaculum filamentous virus 1 Species 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 230000009385 viral infection Effects 0.000 description 6
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 5
- 208000030507 AIDS Diseases 0.000 description 4
- 102100036303 C-C chemokine receptor type 9 Human genes 0.000 description 3
- 101000856683 Homo sapiens C-X-C chemokine receptor type 6 Proteins 0.000 description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
- 102000002791 Interleukin-8B Receptors Human genes 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108010061299 CXCR4 Receptors Proteins 0.000 description 2
- 102100031011 Chemerin-like receptor 1 Human genes 0.000 description 2
- 101710091045 Envelope protein Proteins 0.000 description 2
- 101000980744 Homo sapiens C-C chemokine receptor type 3 Proteins 0.000 description 2
- 101000919756 Homo sapiens Chemerin-like receptor 1 Proteins 0.000 description 2
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 2
- 102100034349 Integrase Human genes 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 108091030146 MiRBase Proteins 0.000 description 2
- 101710188315 Protein X Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 108091008803 APLNR Proteins 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 102000018746 Apelin Human genes 0.000 description 1
- 108010052412 Apelin Proteins 0.000 description 1
- 102100030949 Apelin receptor Human genes 0.000 description 1
- 101100279540 Arabidopsis thaliana EIN2 gene Proteins 0.000 description 1
- 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101150028394 CCR1 gene Proteins 0.000 description 1
- 101150083327 CCR2 gene Proteins 0.000 description 1
- 101150019010 CCR3 gene Proteins 0.000 description 1
- 101150081315 CCR4 gene Proteins 0.000 description 1
- 101150100160 CCR8 gene Proteins 0.000 description 1
- 101150036228 CCR9 gene Proteins 0.000 description 1
- 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
- 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000724252 Cucumber mosaic virus Species 0.000 description 1
- 101150061021 Cxcr2 gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000837299 Euglena gracilis Trans-2-enoyl-CoA reductase Proteins 0.000 description 1
- 102100023416 G-protein coupled receptor 15 Human genes 0.000 description 1
- 101150089139 GPR1 gene Proteins 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 101000777564 Homo sapiens C-C chemokine receptor type 1 Proteins 0.000 description 1
- 101000777599 Homo sapiens C-C chemokine receptor type 2 Proteins 0.000 description 1
- 101000946926 Homo sapiens C-C chemokine receptor type 5 Proteins 0.000 description 1
- 101100219993 Homo sapiens CCR1 gene Proteins 0.000 description 1
- 101100220001 Homo sapiens CCR2 gene Proteins 0.000 description 1
- 101100382963 Homo sapiens CCR3 gene Proteins 0.000 description 1
- 101100112701 Homo sapiens CCR4 gene Proteins 0.000 description 1
- 101100438883 Homo sapiens CCR5 gene Proteins 0.000 description 1
- 101100005658 Homo sapiens CCR8 gene Proteins 0.000 description 1
- 101100005661 Homo sapiens CCR9 gene Proteins 0.000 description 1
- 101100168978 Homo sapiens CXCR2 gene Proteins 0.000 description 1
- 101100497623 Homo sapiens CXCR4 gene Proteins 0.000 description 1
- 101000829794 Homo sapiens G-protein coupled receptor 15 Proteins 0.000 description 1
- 101100015671 Homo sapiens GPR15 gene Proteins 0.000 description 1
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 1
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 101100219997 Mus musculus Ccr1 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241001135893 Themira Species 0.000 description 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 241000101098 Xenotropic MuLV-related virus Species 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- BWVPHIKGXQBZPV-QKFDDRBGSA-N apelin Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCSC)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)CCC1 BWVPHIKGXQBZPV-QKFDDRBGSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004970 cd4 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000007484 viral process Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0956045A FR2949789B1 (fr) | 2009-09-04 | 2009-09-04 | Identification du tropisme cellulaire de virus |
FR0956045 | 2009-09-04 | ||
PCT/FR2010/051817 WO2011027075A1 (fr) | 2009-09-04 | 2010-09-01 | Identification du tropisme cellulaire de virus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102812131A true CN102812131A (zh) | 2012-12-05 |
CN102812131B CN102812131B (zh) | 2016-08-10 |
Family
ID=42077918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080050205.0A Expired - Fee Related CN102812131B (zh) | 2009-09-04 | 2010-09-01 | 病毒细胞嗜性的识别 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9175334B2 (zh) |
EP (1) | EP2473629B8 (zh) |
JP (1) | JP5837496B2 (zh) |
CN (1) | CN102812131B (zh) |
AU (1) | AU2010291028B2 (zh) |
CA (1) | CA2773068A1 (zh) |
ES (1) | ES2537121T3 (zh) |
FR (1) | FR2949789B1 (zh) |
IN (1) | IN2012DN01932A (zh) |
WO (1) | WO2011027075A1 (zh) |
ZA (1) | ZA201202432B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014513699A (ja) * | 2011-05-11 | 2014-06-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | スピロ−オキシインドールmdm2アンタゴニスト |
JP2015512249A (ja) * | 2012-03-19 | 2015-04-27 | プレスティズィアPrestizia | 循環から採取される身体試料中のウイルス、特に、hivの親和性及び受容体使用の決定方法 |
EP2813578A1 (en) * | 2013-06-14 | 2014-12-17 | Prestizia | Methods for detecting an infectious agent, in particular HIV1, using long noncoding RNA |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009033185A1 (en) * | 2007-09-06 | 2009-03-12 | University Of Massachusetts | Virus-specific mirna signatures for diagnosis and therapeutic treatment of viral infection |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7393634B1 (en) * | 1999-10-12 | 2008-07-01 | United States Of America As Represented By The Secretary Of The Air Force | Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes |
-
2009
- 2009-09-04 FR FR0956045A patent/FR2949789B1/fr not_active Expired - Fee Related
-
2010
- 2010-09-01 ES ES10763790.2T patent/ES2537121T3/es active Active
- 2010-09-01 CN CN201080050205.0A patent/CN102812131B/zh not_active Expired - Fee Related
- 2010-09-01 WO PCT/FR2010/051817 patent/WO2011027075A1/fr active Application Filing
- 2010-09-01 EP EP20100763790 patent/EP2473629B8/fr not_active Not-in-force
- 2010-09-01 CA CA2773068A patent/CA2773068A1/fr not_active Abandoned
- 2010-09-01 IN IN1932DEN2012 patent/IN2012DN01932A/en unknown
- 2010-09-01 JP JP2012527369A patent/JP5837496B2/ja not_active Expired - Fee Related
- 2010-09-01 US US13/394,002 patent/US9175334B2/en not_active Expired - Fee Related
- 2010-09-01 AU AU2010291028A patent/AU2010291028B2/en not_active Ceased
-
2012
- 2012-04-03 ZA ZA2012/02432A patent/ZA201202432B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009033185A1 (en) * | 2007-09-06 | 2009-03-12 | University Of Massachusetts | Virus-specific mirna signatures for diagnosis and therapeutic treatment of viral infection |
Non-Patent Citations (2)
Title |
---|
SOULIE C ET AL.: "HIV tropism assays when first CCR5-antagonist becomes available", 《MEDECINE ET MALADIES INFECTIEUSES》 * |
VAN BAELEN ET AL.: "HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays", 《JOURNAL OF VIROLOGICAL METHODS》 * |
Also Published As
Publication number | Publication date |
---|---|
AU2010291028B2 (en) | 2015-11-19 |
US20130040832A1 (en) | 2013-02-14 |
FR2949789A1 (fr) | 2011-03-11 |
FR2949789B1 (fr) | 2011-12-09 |
CN102812131B (zh) | 2016-08-10 |
CA2773068A1 (fr) | 2011-03-10 |
JP5837496B2 (ja) | 2015-12-24 |
AU2010291028A1 (en) | 2012-04-19 |
EP2473629B1 (fr) | 2015-02-25 |
ES2537121T3 (es) | 2015-06-02 |
EP2473629A1 (fr) | 2012-07-11 |
WO2011027075A1 (fr) | 2011-03-10 |
IN2012DN01932A (zh) | 2015-07-24 |
EP2473629B8 (fr) | 2015-05-13 |
JP2013503620A (ja) | 2013-02-04 |
ZA201202432B (en) | 2012-12-27 |
US9175334B2 (en) | 2015-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Swaminathan et al. | Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression | |
Narasipura et al. | Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes | |
Bannert et al. | The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses | |
Peters et al. | Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages | |
Lawrence et al. | Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells | |
Yamamoto et al. | Double‐stranded nef RNA interferes with human immunodeficiency virus type 1 replication | |
Shen et al. | Translation of Pur‐α is targeted by cellular miRNAs to modulate the differentiation‐dependent susceptibility of monocytes to HIV‐1 infection | |
JP2022166288A5 (zh) | ||
Suh et al. | TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS | |
US20150057173A1 (en) | Methods for determining the tropism and receptor usage of a virus, in particular hiv, in body samples taken from the circulation | |
Wong-Staal et al. | Regulatory genes of human immunodeficiency viruses. | |
Andersson et al. | Differential expression of human endogenous retroviral sequences similar to mouse mammary tumor virus in normal peripheral blood mononuclear cells | |
Kim et al. | Microarray analysis of changes in cellular gene expression induced by productive infection of primary human astrocytes: implications for HAD | |
CN102812131A (zh) | 病毒细胞嗜性的识别 | |
Bagasra | RNAi as an antiviral therapy | |
US9567634B2 (en) | Method for detecting or measuring the impact of a viral vector composition on eukaryotic cells and biomarkers used thereof | |
CN114081950B (zh) | Crem/icer基因或其转录体作为靶点在制备抗hiv药物中的应用 | |
Li et al. | Inhibition of CXCR4 expression by recombinant adenoviruses containing anti-sense RNA resists HIV-1 infection on MT4 cell lines | |
Havlicek | The Role of the Host Factor SPTBN1 in HIV-1 Infection of Microglial Cells | |
Fiorucci et al. | Microarray analysis reveals CCL24/eotaxin-2 as an effector of the pathogenetic effects induced by HIV-1 Nef | |
Matheney | The Role of Actin Associated SPTBN1 Host Factor in HIV-1 Infection in Microglial Cells | |
Xiao | Neuroprotective micrornas combat HIV-1 associated neurocognitive disorder (HAND) pathogenesis | |
Li et al. | Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors | |
CN102604994A (zh) | 一种针对flg基因rna干扰的重组慢病毒载体及其制备 | |
Saayman | Inhibiting HIV-1 gene expression and replication with expressed long hairpin RNAs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ASSIST PUBL HOPITAUX DE PARIS UNIVERSITY OF TECHNO Free format text: FORMER OWNER: ASSIST PUBL HOPITAUX DE PARIS Effective date: 20130516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130516 Address after: France Applicant after: National Center for scientific research Applicant after: France Public Assisted Hosiptal Applicant after: Mengboliaidi two University of science and technology Applicant after: Univ of Paris 7 Address before: France Applicant before: National Center for scientific research Applicant before: France Public Assisted Hosiptal |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160810 Termination date: 20170901 |
|
CF01 | Termination of patent right due to non-payment of annual fee |